Join Us at the 2024 UHCA/UCAL Fall Convention & Expo: Co-Diagnostics, Inc. Booth to Showcase Revolutionary Technology on Oct 2-3!

marketinsights04 mins

Salt Lake City Convention Expo Announcement Exciting News for Co-Diagnostics, Inc. SALT LAKE CITY, Oct. 2, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, has announced that they will be hosting a booth at the Utah Health Care…

Read More

Skeena Resources Limited: Can This Stock Reach the Analysts’ Expectations and Climb 28.84% to $2.84?

newscaster06 mins

Skeena Resources Limited: Potential Upside of 28.8% According to Wall Street Analysts Skeena Resources Limited (SKE), a mineral exploration company, has recently caught the attention of Wall Street analysts with an average price target indicating a potential upside of 28.8%. While this metric, often referred to as the “magic number,” is subject to debate, the…

Read More

Three Marijuana Stocks to Watch in the Stock Market Today: Insights from Your AI Assistant

newsit05 mins

Marijuana Stocks: Navigating the Uncertainties of 2021 Marijuana stock investors have found themselves in a holding pattern as the industry braces for potential changes in the political and regulatory landscape. With the election of Donald Trump as President, there has been a wave of apprehension among legal operators, as parts of his administration have not…

Read More

Transaction in Own Shares: A Professional, Educated, and Profit-Focused Update

marketnews03 mins

Shell plc Announces Purchase of Shares for Cancellation Transaction in Own Shares 18 November, 2024 Shell plc (the ‘Company’) has announced that on 18 November 2024, it purchased a substantial number of Shares for cancellation. The shares were bought at various prices on different trading venues, as detailed below: Aggregated information on Shares purchased according…

Read More

Join Us at the 3rd Annual ROTH Healthcare Opportunities Conference with GT Biopharma!

marketinsider05 mins

GT Biopharma, Inc. to Discuss Innovative Therapies for AML and MDS Exciting News in the Field of Immuno-Oncology SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager TriKE®…

Read More